| | Presentation | Media | Date |
| AlzeCure medverkar på Erik Penser Banks temadag Life Science den 2 december, 2021
|
|
|
2 december, 2021
|
| Follow us - Stay updated
|
|
|
22 november, 2021
|
| AlzeCure Pharma - Redeye Life Science Day
|
|
|
11 november, 2021
|
| AlzeCure update on the latest developments - Interview with CEO Martin Jönsson about the company, its projects developments in Alzheimer’s and pain, and future plans.
| |
|
22 oktober, 2021
|
| Alzecure presents at Healthcare Innovation Summit
|
|
|
7 oktober, 2021
|
| Characterization of positive allosteric modulators of TrkB for the treatment of depression
|
|
|
2 oktober, 2021
|
| Alzecure Pharma - Naventus Life Science Summit
|
|
|
29 september, 2021
|
| Aktiespararna intervjuar VD Martin Jönsson - senaste kvartalsrapporten och framtidsutsikterna
| |
|
20 september, 2021
|
| AlzeCure Pharma – Aktiedagen Stockholm
| |
|
7 september, 2021
|
| Development plan for NeuroRestore ACD856 by Dr Johan Sandin, PhD Chief Scientific Officer
|
|
|
1 september, 2021
|
| NeuroRestore Background and evolution by Dr Pontus Forsell, PhD Head of Discovery & Research
|
|
|
1 september, 2021
|
| Company Overview & Vision by Martin Jönsson CEO
|
|
|
1 september, 2021
|
| Alzheimer’s disease and the neurotrophins BDNF/NGF by Prof. Maria Eriksdotter M.D., PhD
|
|
|
1 september, 2021
|
| Strategy Update on Alzheimer’s Disease & NeuroRestore
|
|
|
1 september, 2021
|
| ACD856 – a novel positive allosteric modulator of Trk-receptors in clinical development for the treatment of Alzheimer’s disease; Scientific presentation at AAIC, July 26-30, 2021
|
|
|
29 juli, 2021
|
| Negativa allosteriska modulatorer av TrkA för behandling av smärta - Vetenskaplig presentation på smärtkonferensen IASP, juni 2021
|
|
|
11 juni, 2021
|
| Om att drabbas av Alzheimers sjukdom, diagnostik, vården idag samt framtida behov - med Bengt Winblad, professor, senior vid Karolinska Institutet.
| |
|
11 juni, 2021
|
| Om Alzstatin och läkemedel vid Alzheimers sjukdom - med Bengt Winblad, professor, senior vid Karolinska Institutet.
| |
|
11 juni, 2021
|
| Om AlzeCures uppkomst och utveckling - Ett embryo som kan bli något stort - med Bengt Winblad, professor, senior vid Karolinska Institutet.
| |
|
11 juni, 2021
|
| ACD440 – A Novel TRPV1 Antagonist for the Topical Treatment in Neuropathic Pain - Vetenskaplig presentation på smärtkonferensen IASP, juni 2021
|
|
|
9 juni, 2021
|
| Alzecure: VD Martin Jönsson presenterar på Redeye Growth Day
| |
|
7 juni, 2021
|
| CEO Martin Jönsson after the company's annual meeting
| |
|
17 maj, 2021
|
| Update on Progress in the Painless Platform, May 11, 2021
|
|
|
11 maj, 2021
|
| Company overview and goals by CEO Martin Jönsson, 11 Maj, 2021
|
| |
11 maj, 2021
|
| Chronic Pain – a high unmet medical need by CMO Märta Segerdahl, 11 Maj, 2021
|
|
|
11 maj, 2021
|
| ACD 440 – A novel VR1 antagonist for neuropathic pain by CSO Johan Sandin, 11 Maj, 2021
|
|
|
11 maj, 2021
|
| TrkA- NAM – Project in osteoarthritis & other severe pain conditions by Head of Discovery & Research Pontus Forsell, 11 Maj, 2021
|
|
|
11 maj, 2021
|
| Alzecure: Interview with CEO Martin Jönsson and CSO Johan Sandin (video)
| |
|
20 april, 2021
|
| Analysguiden: "Smärtprojekt, en dold diamant”
|
| |
10 mars, 2021
|
| Alzecure: Intervju med vd Martin Jönsson (video)
| |
|
1 mars, 2021
|
| Analysguiden: Intervju med AlzeCure Pharma "Vi har tagit stora kliv under 2020"
| |
|
8 februari, 2021
|
| VD Martin Jönsson presentation, Aktiedagen Lund
| |
|
27 januari, 2021
|
| Intervju med Johan Sandin (CSO) i Aktiespararnas analysguide
| |
|
22 januari, 2021
|
| Improving Quality of Life for People with Neurodegenerative Diseases – Stockholm Researchers and Health Tech Companies
|
| |
14 januari, 2021
|
